3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioma
4
Pancreatic Neoplasms
3
Melanoma
3
Colorectal Neoplasms
3
Wilms Tumor
2
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Stomach Neoplasms
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Ovarian Neoplasms
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Neoplasms
2
Multiple Myeloma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Esophageal Neoplasms
2
Ependymoma
2
Carcinoma, Hepatocellular
2
Xanthogranuloma, Juvenile
1
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Interventions
fludarabine
52
Cyclophosphamide
50
venetoclax
47
Azacitidine
44
fludarabine phosphate
41
Whole-Body Irradiation
33
Specimen Handling
31
Mycophenolic Acid
30
Tacrolimus
28
Melphalan
28
Busulfan
27
Cytarabine
25
Stem Cell Transplantation
23
Decitabine
23
Biopsy
22
Granulocyte Colony-Stimulating Factor
19
Sirolimus
16
Peripheral Blood Stem Cell Transplantation
16
Filgrastim
16
Thiotepa
15
decitabine and cedazuridine drug combination
14
Injections
13
Cyclosporine
13
Methotrexate
9
Mesna
9
Hematopoietic Stem Cell Transplantation
9
ruxolitinib
8
X-Rays
8
Idarubicin
8
Daunorubicin
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
ulixertinib
×
1 year
×
Clear all
No trials found.